Dermatology: Archives

SUMMARY AND COMMENT

Creaming Pemphigoid

• August 28, 2009
• Mark V. Dahl, MD

Less-frequent clobetasol treatment worked as well as the standard regimen and was safer.

• Reviewing:
• Joly P et al., J Invest Dermatol 2009 Jul; 129:1681

SUMMARY AND COMMENT

CD30⁺ Lymphoproliferative Disease: The Mysterious Case of the Leg

• August 28, 2009
• Angelica Maria Selim, MD

The prognosis is different for older patients with extensive leg disease.

• Reviewing:
• Woo DK et al., Arch Dermatol 2009 Jun; 145:667

SUMMARY AND COMMENT

Condoms Prevent Herpes Simplex Virus Type 2!

• August 21, 2009
• Jeffrey P. Callen, MD

Consistent users had a significantly reduced risk for genital herpes infection compared with never users.

• Reviewing:
• Martin ET et al., Arch Intern Med 2009 Jul 13; 169:1233

SUMMARY AND COMMENT

Dissecting BCC RiskFree

• August 21, 2009
• Hensin Tsao, MD, PhD

Some genetic components of the risk for basal cell carcinoma have nothing to do with pigmentation.

• Reviewing:
• Stacey SN et al., Nat Genet 2009 Aug; 41:909

SUMMARY AND COMMENT

Acne Is Common, Complex, and Chronic

• August 21, 2009
• Mary Wu Chang, MD

The Global Alliance to Improve Outcomes in Acne compiled recent data and opinions on acne management and provides updated recommendations.

• Reviewing:
• Thiboutot D et al., J Am Acad Dermatol 2009 May; 60:S1

SUMMARY AND COMMENT

Danger Lurks in the Laboratory

• August 21, 2009
• Jan V. Hirschmann, MD

An unimmunized lab worker developed vaccinia infection.

• Reviewing:
• Centers for Disease Control and Prevention (CDC)., MMWR Morb Mortal Wkly Rep 2009 Jul 31; 58:797

SUMMARY AND COMMENT

Photodynamic Therapy and the Immune System

• August 14, 2009
• Craig A. Elmets, MD

PDT apparently increases antitumor immunity in addition to directly destroying lesions of basal cell carcinoma.

• Reviewing:
• Kabingu E et al., Clin Cancer Res 2009 Jul 1; 15:4460

FEATURE

Briefly Noted

• August 14, 2009
• Jeffrey P. Callen, MD

Rituximab promising for bullous diseases, current knowledge of psoriasis pathogenesis, early and aggressive treatment for juvenile dermatomyositis

• Reviewing:
• Peterson JD and Chan LS., Ther Clin Risk Manag 2009 ; 5:1 Nestle FO et al., N Engl J Med 2009 Jul 30; 361:496 Kim S et al., Arthritis Rheum 2009 Jun; 60:1825

SUMMARY AND COMMENT

Filaggrin–Atopy Update

• August 14, 2009
• Mark V. Dahl, MD

In a meta-analysis, persons with filaggrin mutations were significantly more likely to have atopic dermatitis (and allergic rhinitis).

• Reviewing:
• van den Oord RAHM and Sheikh A., BMJ 2009 Jul 9; 339:b2433

SUMMARY AND COMMENT

Vitamin D and Psoriasis: A Cause for Alarm(ins)

• August 14, 2009
• Craig A. Elmets, MD

Peptides that activate the immune response may be a fruitful new target for psoriasis therapy.

• Reviewing:
• Peric M et al., PLoS One 2009 Jul 22; 4:e6340